~7% for tirzepatide in SURMOUNT-1) and a new dysesthesia signal at ~21% incidence that didn't appear in Phase 2
Common reasons include BMI not meeting requirements, missing documentation, no qualifying comorbidities, excluded benefits, incomplete prior authorization, or step therapy requirements
The latter is another good choice for the formula its in, as a 2022 study concluded that it may help prevent metabolic disorders associated with a high-fat diet (in mice).31 Again, though, were talking about a large dose, with the study calculating a human-equivalent dose to be 1020g per day
Lipovia positions itself as activating your bodys natural GLP-1, not replacing it with a drug
(1) Dissolve arginine and glycine in an appropriate amount of dichloromethane, add an appropriate amount of acetic anhydride and triethylamine, and stir evenly under a stirrer